Loren Pickart, then a graduate student at the University of California, San Francisco
With GLP-1 medication as a key component of our thorough approach, we empower our patients to take control of their health and well-being, enabling them to lead more active, fulfilling lives
GLP-1 RAs have demonstrated favorable trends toward improving endocrine and metabolic outcomes, including reductions in ALT, AST, HbA1c, body weight, BMI, LFC, and IHA
Ozempic is an injectable prescription drug developed to manage blood sugar levels in patients with Type 2 diabetes
The 3 month lag was introduced for clinical and long-term outcomes to allow for an adequate amount of time to achieve some meaningful efficacy